Gérard Zalcman MD, PhD
Professor of Pulmonology, Université Paris Cité; Chair, Thoracic Oncology Department, Bichat Hospital, Assistance Publique-Hôpitaux de Paris; Medical Director, Institute of Cancer AP-HP.Nord, Paris, FranceGérard Zalcman, MD, PhD, is full professor of Pulmonology at Université Paris Cité, Paris, France and chairs the Thoracic Oncology Department of Bichat Hospital, at Assistance Publique-Hôpitaux de Paris. He serves as medical Director of the Institute of Cancer AP-HP.Nord. He is the senior author of the three randomized trials pubished in Lancet and Lancet Oncol journals, which established the current standard treatments for mesothelioma, either pemetrexed-based chemotherapy plus bevacizumab, or the immunotherapy combo Nivolumab+ipilimumab.